Stephen Davis | Chief Executive Officer |
Mark Johnson | Vice President of Investor Relations |
Brendan Teehan | Chief Operating Officer and Head of Commercial |
Serge Stankovic | President |
Mark Schneyer | Interim Chief Financial Officer |
Neena Bitritto-Garg | Citi |
Gavin Scott | JPMorgan |
Ritu Baral | Cowan |
Charles Duncan | Cantor Fitzgerald |
Yatin Suneja | Guggenheim Partners |
Marc Goodman | SVB Leerink |
Gregory Renza | RBC Capital Markets |
Ami Fadia | Needham |
Paul Matthias | Stifel |
Jeff Hung | Morgan Stanley |
Good day, ladies and gentlemen. And welcome to the ACADIA Pharmaceuticals Third Quarter 2021 Financial Results Conference Call. My name is Gigi and I'll be your coordinator for today. I would now like to turn the presentation over to Mark Johnson, Vice President of Investor Relations at Acadia. Please proceed.